Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
;
Martine
Dumont
;
Lorraine
Durcan
;
Miriam
Dwek
;
Diana M
Eccles
;
Arif B
Ekici
;
A Heather
Eliassen
;
Carolina
Ellberg
;
Christoph
Engel
;
Mikael
Eriksson
;
D Gareth
Evans
;
Peter A
Fasching
;
Jonine
Figueroa
;
Olivia
Fletcher
;
Henrik
Flyger
;
Asta
Försti
;
Lin
Fritschi
;
Marike
Gabrielson
;
Manuela
Gago-Dominguez
;
Susan M
Gapstur
;
José A
García-Sáenz
;
Mia M
Gaudet
;
Vassilios
Georgoulias
;
Graham G
Giles
;
Irina R
Gilyazova
;
Gord
Glendon
;
Mark S
Goldberg
;
David E
Goldgar
;
Anna
González-Neira
;
Grethe I
Grenaker Alnæs
;
Mervi
Grip
;
Jacek
Gronwald
;
Anne
Grundy
;
Pascal
Guénel
;
Lothar
Haeberle
;
Eric
Hahnen
;
Christopher A
Haiman
;
Niclas
Håkansson
;
Ute
Hamann
;
Susan E
Hankinson
;
Elaine F
Harkness
;
Steven N
Hart
;
Wei
He
;
Alexander
Hein
;
Jane
Heyworth
;
Peter
Hillemanns
;
Antoinette
Hollestelle
;
Maartje J
Hooning
;
Robert N
Hoover
;
John L
Hopper
;
Anthony
Howell
;
Guanmengqian
Huang
;
Keith
Humphreys
;
David J
Hunter
;
Milena
Jakimovska
;
Anna
Jakubowska
;
Wolfgang
Janni
;
Esther M
John
;
Nichola
Johnson
;
Michael E
Jones
;
Arja
Jukkola-Vuorinen
;
Audrey
Jung
;
Rudolf
Kaaks
;
Katarzyna
Kaczmarek
;
Vesa
Kataja
;
Renske
Keeman
;
Michael J
Kerin
;
Elza
Khusnutdinova
;
Johanna I
Kiiski
;
Julia A
Knight
;
Yon-Dschun
Ko
;
Veli-Matti
Kosma
;
Stella
Koutros
;
Vessela N
Kristensen
;
Ute
Krüger
;
Tabea
Kühl
;
Diether
Lambrechts
;
Loic
Le Marchand
;
Eunjung
Lee
;
Flavio
Lejbkowicz
;
Jenna
Lilyquist
;
Annika
Lindblom
;
Sara
Lindström
;
Jolanta
Lissowska
;
Wing-Yee
Lo
;
Sibylle
Loibl
;
Jirong
Long
;
Jan
Lubiński
;
Michael P
Lux
;
Robert J
MacInnis
;
Tom
Maishman
;
Enes
Makalic
;
Ivana
Maleva Kostovska
;
Arto
Mannermaa
;
Siranoush
Manoukian
;
Sara
Margolin
;
John WM
Martens
;
Maria Elena
Martinez
;
Dimitrios
Mavroudis
;
Catriona
McLean
;
Alfons
Meindl
;
Usha
Menon
;
Pooja
Middha
;
Nicola
Miller
;
Fernando
Moreno
;
Anna Marie
Mulligan
;
Claire
Mulot
;
Victor M
Muñoz-Garzon
;
Susan L
Neuhausen
;
Heli
Nevanlinna
;
Patrick
Neven
;
William G
Newman
;
Sune F
Nielsen
;
Børge G
Nordestgaard
;
Aaron
Norman
;
Kenneth
Offit
;
Janet E
Olson
;
Håkan
Olsson
;
Nick
Orr
;
V Shane
Pankratz
;
Tjoung-Won
Park-Simon
;
Jose IA
Perez
;
Clara
Pérez-Barrios
;
Paolo
Peterlongo
;
Julian
Peto
;
Mila
Pinchev
;
Dijana
Plaseska-Karanfilska
;
Eric C
Polley
;
Ross
Prentice
;
Nadege
Presneau
;
Darya
Prokofyeva
;
Kristen
Purrington
;
Katri
Pylkäs
;
Brigitte
Rack
;
Paolo
Radice
;
Rohini
Rau-Murthy
;
Gad
Rennert
;
Hedy S
Rennert
;
Valerie
Rhenius
;
Mark
Robson
;
Atocha
Romero
;
Kathryn J
Ruddy
;
Matthias
Ruebner
;
Emmanouil
Saloustros
;
Dale P
Sandler
;
Elinor J
Sawyer
;
Daniel F
Schmidt
;
Rita K
Schmutzler
;
Andreas
Schneeweiss
;
Minouk J
Schoemaker
;
Fredrick
Schumacher
;
Peter
Schürmann
;
Lukas
Schwentner
;
Christopher
Scott
;
Rodney J
Scott
;
Caroline
Seynaeve
;
Mitul
Shah
;
Mark E
Sherman
;
Martha J
Shrubsole
;
Xiao-Ou
Shu
;
Susan
Slager
;
Ann
Smeets
;
Christof
Sohn
;
Penny
Soucy
;
Melissa C
Southey
;
John J
Spinelli
;
Christa
Stegmaier
;
Jennifer
Stone
;
Anthony J
Swerdlow
;
Rulla M
Tamimi
;
William J
Tapper
;
Jack A
Taylor
;
Mary Beth
Terry
;
Kathrin
Thöne
;
Rob AEM
Tollenaar
;
Ian
Tomlinson
;
Thérèse
Truong
;
Maria
Tzardi
;
Hans-Ulrich
Ulmer
;
Michael
Untch
;
Celine M
Vachon
;
Elke M
van Veen
;
Joseph
Vijai
;
Clarice R
Weinberg
;
Camilla
Wendt
;
Alice S
Whittemore
;
Hans
Wildiers
;
Walter
Willett
;
Robert
Winqvist
;
Alicja
Wolk
;
Xiaohong R
Yang
;
Drakoulis
Yannoukakos
;
Yan
Zhang
;
Wei
Zheng
;
Argyrios
Ziogas
;
ABCTB Investigators
;
kConFab/AOCS Investigators
;
NBCS Collaborators
;
Alison M
Dunning
;
Deborah J
Thompson
;
Georgia
Chenevix-Trench
;
Jenny
Chang-Claude
;
Marjanka K
Schmidt
;
Per
Hall
;
Roger L
Milne
;
Paul DP
Pharoah
;
Antonis C
Antoniou
;
Nilanjan
Chatterjee
;
Peter
Kraft
;
Montserrat
García-Closas
;
Jacques
Simard
;
Douglas F
Easton
;
(2018)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
AMERICAN JOURNAL OF HUMAN GENETICS, 104 (1).
pp. 21-34.
ISSN 0002-9297
DOI: 10.1016/j.ajhg.2018.11.002
Stratification of women according to their risk of breast cancer based on polygenic risk scores (PRSs) could improve screening and prevention strategies. Our aim was to develop PRSs, optimized for prediction of estrogen receptor (ER)-specific disease, from the largest available genome-wide association dataset and to empirically validate the PRSs in prospective studies. The development dataset comprised 94,075 case subjects and 75,017 control subjects of European ancestry from 69 studies, divided into training and validation sets. Samples were genotyped using genome-wide arrays, and single-nucleotide polymorphisms (SNPs) were selected by stepwise regression or lasso penalized regression. The best performing PRSs were validated in an independent test set comprising 11,428 case subjects and 18,323 control subjects from 10 prospective studies and 190,040 women from UK Biobank (3,215 incident breast cancers). For the best PRSs (313 SNPs), the odds ratio for overall disease per 1 standard deviation in ten prospective studies was 1.61 (95%CI: 1.57-1.65) with area under receiver-operator curve (AUC) = 0.630 (95%CI: 0.628-0.651). The lifetime risk of overall breast cancer in the top centile of the PRSs was 32.6%. Compared with women in the middle quintile, those in the highest 1% of risk had 4.37- and 2.78-fold risks, and those in the lowest 1% of risk had 0.16- and 0.27-fold risks, of developing ER-positive and ER-negative disease, respectively. Goodness-of-fit tests indicated that this PRS was well calibrated and predicts disease risk accurately in the tails of the distribution. This PRS is a powerful and reliable predictor of breast cancer risk that may improve breast cancer prevention programs.
-
picture_as_pdf - mavaddat_etal_2019_polygenic_risk_scores_prediction_breast_cancer.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0